Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(-) in chronic systolic heart failure patients

Area of Science:

• Immunology
• Cardiology
• Biomedical Science

Background:

• Monocytic subsets play roles in inflammation and tissue remodeling.
• Heart failure (HF) involves inflammation, but monocytic subset roles in HF remain unclear.

Purpose of the Study:

• To investigate the distribution and function of monocytic subsets in chronic systolic heart failure patients.
• To explore the relationship between monocytic subsets, inflammation, and cardiac remodeling in HF.

Main Methods:

• Flow cytometry was used to analyze monocytic subsets (CD14++CD16-, CD14+CD16+, CD14dimCD16+) in 59 HF patients and 29 controls.
• Serum cytokine levels (TNFα, IL-1β, IL-10, IL-13) were measured.
• Intracellular cytokine staining was performed to identify cytokine-producing monocytes.

Main Results:

• HF patients showed decreased classical (CD14++CD16-) and expanded nonclassical (CD14dimCD16+) monocyte subsets compared to controls.
• The expansion of nonclassical monocytes was inversely associated with HF severity (increased end-diastolic dimension).
• Serum IL-13 levels were elevated in HF patients and positively correlated with the nonclassical monocyte subset, which was found to produce IL-13.

Conclusions:

• The altered distribution of monocytic subsets in HF may reflect an attempt to counterbalance adverse cardiac remodeling.
• Nonclassical monocytes producing IL-13 might play a protective role in mitigating HF-associated tissue remodeling.